Arabian International Healthcare Holding Company (TADAWUL:9530)
Saudi Arabia · Delayed Price · Currency is SAR 16.22
0.00 (0.00%)
Sep 22, 2026, 2:45 PM AST
TADAWUL:9530 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 840.73 | 842.21 | 739.28 | 806.92 | 642.67 | 618.54 | |
Revenue Growth | 7.87% | 13.92% | -8.38% | 25.56% | 3.90% | -24.45% |
Cost of Revenue | 643.83 | 647.45 | 566.99 | 616.89 | 488.51 | 475.02 |
Gross Profit | 196.9 | 194.77 | 172.29 | 190.04 | 154.16 | 143.52 |
Selling, General & Admin | 131.92 | 129.28 | 118.34 | 136.79 | 113.62 | 90.96 |
Other Operating Expenses | -12.24 | -9.99 | -13.64 | -13.1 | -9.56 | -11 |
Operating Expenses | 117.44 | 119.11 | 122.23 | 130.21 | 100.58 | 62.42 |
Operating Income | 79.46 | 75.66 | 50.06 | 59.82 | 53.58 | 81.09 |
Interest Expense | -30.08 | -29.14 | -38.17 | -36.16 | -18.51 | -13 |
Interest & Investment Income | 2.01 | 1.83 | 2.14 | 5.1 | 0.72 | - |
Earnings From Equity Investments | -1.52 | -1.54 | -5.76 | -2.04 | 7.79 | 11.5 |
Currency Exchange Gain (Loss) | -1.07 | -1.07 | -0.94 | -0.52 | -0.81 | -0.11 |
Other Non Operating Income (Expenses) | -6.98 | -6.98 | -2.35 | -0.4 | -0.05 | -0.37 |
EBT Excluding Unusual Items | 41.82 | 38.76 | 4.98 | 25.8 | 42.71 | 79.11 |
Impairment of Goodwill | - | - | -93.66 | -17.2 | - | - |
Other Unusual Items | - | - | 34.16 | 45.32 | -6.12 | 14.63 |
Pretax Income | 41.82 | 38.76 | -54.52 | 53.92 | 36.59 | 93.74 |
Income Tax Expense | 10.17 | 10.17 | 7.81 | 11.57 | 10.89 | 11.42 |
Earnings From Continuing Operations | 31.64 | 28.59 | -62.33 | 42.35 | 25.71 | 82.31 |
Earnings From Discontinued Operations | -4.88 | -9.6 | -8.41 | - | - | - |
Net Income to Company | 26.76 | 18.99 | -70.73 | 42.35 | 25.71 | 82.31 |
Minority Interest in Earnings | 2.3 | 4.61 | 4.12 | -4.26 | -5.23 | - |
Net Income | 29.06 | 23.6 | -66.61 | 38.09 | 20.47 | 82.31 |
Net Income to Common | 29.06 | 23.6 | -66.61 | 38.09 | 20.47 | 82.31 |
Net Income Growth | - | - | - | 86.03% | -75.13% | -14.07% |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Change | - | - | - | -0.94% | -0.11% | 1430.22% |
EPS (Basic) | 1.47 | 1.19 | -3.37 | 1.92 | 1.02 | 4.12 |
EPS (Diluted) | 1.47 | 1.19 | -3.37 | 1.92 | 1.02 | 4.12 |
EPS Growth | - | - | - | 87.80% | -75.10% | -94.38% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 48.21 | -2.07 | 102.28 | 4.21 | 57.49 | 129.11 |
Free Cash Flow Per Share | 2.44 | -0.10 | 5.17 | 0.21 | 2.88 | 6.46 |
Dividend Per Share | - | - | - | - | 1.000 | 3.000 |
Dividend Growth | - | - | - | - | -66.67% | -26.83% |
Gross Margin | 23.42% | 23.13% | 23.30% | 23.55% | 23.99% | 23.20% |
Operating Margin | 9.45% | 8.98% | 6.77% | 7.41% | 8.34% | 13.11% |
Profit Margin | 3.46% | 2.80% | -9.01% | 4.72% | 3.19% | 13.31% |
Free Cash Flow Margin | 5.73% | -0.25% | 13.84% | 0.52% | 8.95% | 20.87% |
EBITDA | 83.16 | 85.83 | 60.92 | 68.91 | 58.57 | 84.74 |
EBITDA Margin | 9.89% | 10.19% | 8.24% | 8.54% | 9.11% | 13.70% |
D&A For EBITDA | 3.7 | 10.18 | 10.86 | 9.08 | 4.99 | 3.65 |
EBIT | 79.46 | 75.66 | 50.06 | 59.82 | 53.58 | 81.09 |
EBIT Margin | 9.45% | 8.98% | 6.77% | 7.41% | 8.34% | 13.11% |
Effective Tax Rate | 24.32% | 26.24% | - | 21.46% | 29.75% | 12.19% |